{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:18:07Z","timestamp":1790029087174,"version":"4.0.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009781","name":"Australian Centre for HIV and Hepatitis Virology Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ebiom.2025.106004","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T06:58:23Z","timestamp":1763189903000},"page":"106004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pomalidomide enhances CD8+ T and NK cell mediated killing of HIV-infected cells"],"prefix":"10.1016","volume":"122","author":[{"given":"Rachel D.","family":"Pascoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Gubser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Judy","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Utzschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Barrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Shi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Y.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajantha","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0330-8241","authenticated-orcid":false,"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ebiom.2025.106004_bib1","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","article-title":"Research priorities for an HIV cure: international AIDS Society Global Scientific Strategy 2021","volume":"27","author":"Deeks","year":"2021","journal-title":"Nat Med"},{"issue":"26","key":"10.1016\/j.ebiom.2025.106004_bib2","doi-asserted-by":"crossref","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106004_bib3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106004_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004251","article-title":"T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection","volume":"10","author":"Buggert","year":"2014","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106004_bib5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.4049\/jimmunol.2300672","article-title":"Persistence of a skewed repertoire of NK cells in people with HIV-1 on long-term antiretroviral therapy","volume":"212","author":"Anderko","year":"2024","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000001887","article-title":"PD-1 expression in HIV-specific CD8+ T cells before antiretroviral therapy is associated with HIV persistence","volume":"80","author":"Ghiglione","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ebiom.2025.106004_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103840","article-title":"Immune checkpoint blockade in HIV","volume":"76","author":"Gubser","year":"2022","journal-title":"eBioMedicine"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106004_bib8","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.immuni.2021.08.007","article-title":"Functional impairment of HIV-specific CD8+ T cells precedes aborted spontaneous control of viremia","volume":"54","author":"Collins","year":"2021","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106004_bib9","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1073\/pnas.0409872102","article-title":"Characterization of CD56\u2013\/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals","volume":"102","author":"Mavilio","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.106004_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.811091","article-title":"Immune dysfunctions of CD56neg NK cells are associated with HIV-1 disease progression","volume":"12","author":"Cao","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106004_bib11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/14787210.2023.2273919","article-title":"Clinical trials aimed at HIV cure or remission: new pathways and lessons learned","volume":"21","author":"Schou","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106004_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00109-016-1450-z","article-title":"The molecular mechanism of thalidomide analogs in hematologic malignancies","volume":"94","author":"Lindner","year":"2016","journal-title":"J Mol Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106004_bib13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/10428194.2012.723708","article-title":"Pomalidomide and myeloma meningitis","volume":"54","author":"Gertz","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106004_bib14","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106004_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.12708","article-title":"Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN","volume":"164","author":"Gandhi","year":"2014","journal-title":"Br J Haematol"},{"issue":"18","key":"10.1016\/j.ebiom.2025.106004_bib16","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2011-05-356063","article-title":"Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide","volume":"118","author":"Zhu","year":"2011","journal-title":"Blood"},{"issue":"6168","key":"10.1016\/j.ebiom.2025.106004_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.ebiom.2025.106004_bib18","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1182\/blood-2014-11-611426","article-title":"Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets","volume":"125","author":"Sehgal","year":"2015","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.ebiom.2025.106004_bib19","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1182\/blood.V124.21.4128.4128","article-title":"Pomalidomide induces expansion of activated and central memory CD4+ and CD8+ T cells in vivo in patients with and without HIV infection","volume":"124","author":"Polizzotto","year":"2014","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.ebiom.2025.106004_bib20","doi-asserted-by":"crossref","first-page":"9351","DOI":"10.1128\/JVI.00472-12","article-title":"Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs","volume":"86","author":"De Keersmaecker","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2025.106004_bib21","article-title":"Transient viral activation in human T cell leukemia virus type 1-Infected macaques treated with pomalidomide","volume":"9","author":"Gutowska","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ebiom.2025.106004_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01676-24","article-title":"Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir","volume":"99","author":"Pascoe","year":"2025","journal-title":"J Virol"},{"issue":"34","key":"10.1016\/j.ebiom.2025.106004_bib23","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1200\/JCO.2016.69.3812","article-title":"Pomalidomide for symptomatic kaposi's sarcoma in people with and without HIV infection: a phase I\/II study","volume":"34","author":"Polizzotto","year":"2016","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106004_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108165","article-title":"GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy","volume":"26","author":"Gubser","year":"2023","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106004_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103231","article-title":"Protocol for measuring killing capacity and intracellular cytokine production of human HIV antigen-specific CD8 T cells using flow cytometry","volume":"5","author":"Gubser","year":"2024","journal-title":"STAR Protoc"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106004_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2025.106004_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/978-1-4939-3572-7_13","article-title":"Optimizing RNA-Seq mapping with STAR","volume":"1415","author":"Dobin","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106004_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt214","article-title":"The subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Liao","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"10.1016\/j.ebiom.2025.106004_bib29","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1093\/bioinformatics\/btm453","article-title":"Moderated statistical tests for assessing differences in tag abundance","volume":"23","author":"Robinson","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2025.106004_bib30","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106004_bib31","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/ncomms3464","article-title":"Master regulators of FGFR2 signalling and breast cancer risk","volume":"4","author":"Fletcher","year":"2013","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106004_bib32","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106004_bib33","first-page":"42","article-title":"An improved flow cytometry-based natural killer cytotoxicity assay involving Calcein AM staining of effector cells","volume":"42","author":"Jang","year":"2012","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.ebiom.2025.106004_bib34","article-title":"Combination immune checkpoint blockade to reverse HIV latency","author":"der Sluis","year":"2020","journal-title":"The J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106004_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106004_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008151","article-title":"Diverse effects of interferon alpha on the establishment and reversal of HIV latency","volume":"16","author":"Van der Sluis","year":"2020","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106004_bib37","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1128\/JVI.02717-15","article-title":"Antibody-dependent cellular cytotoxicity against reactivated HIV-1-Infected cells","volume":"90","author":"Lee","year":"2016","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106004_bib38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/bjh.13905","article-title":"Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myeloma","volume":"172","author":"Rychak","year":"2016","journal-title":"Br J Haematol"},{"issue":"17","key":"10.1016\/j.ebiom.2025.106004_bib39","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/blood-2010-04-279893","article-title":"Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma","volume":"116","author":"G\u00f6rg\u00fcn","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106004_bib40","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/QAD.0000000000003627","article-title":"Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration","volume":"37","author":"Lurain","year":"2023","journal-title":"AIDS"},{"issue":"82","key":"10.1016\/j.ebiom.2025.106004_bib41","doi-asserted-by":"crossref","DOI":"10.3791\/51105-v","article-title":"Cell-based flow cytometry assay to measure cytotoxic activity","author":"Noto","year":"2013","journal-title":"J Vis Exp"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106004_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41590-018-0311-z","article-title":"The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity","volume":"20","author":"Gautam","year":"2019","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106004_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/carcin\/bgp002","article-title":"A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence","volume":"30","author":"Alvaro-Blanco","year":"2009","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106004_bib44","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s41590-020-0786-2","article-title":"BATF3 programs CD8+ T cell memory","volume":"21","author":"Ataide","year":"2020","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106004_bib45","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1038\/s41467-021-25379-9","article-title":"Super-enhancer-based identification of a BATF3\/IL-2R\u2212module reveals vulnerabilities in anaplastic large cell lymphoma","volume":"12","author":"Liang","year":"2021","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106004_bib46","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","article-title":"Early precursor T cells establish and propagate T cell exhaustion in chronic infection","volume":"21","author":"Utzschneider","year":"2020","journal-title":"Nat Immunol"},{"issue":"16","key":"10.1016\/j.ebiom.2025.106004_bib47","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1074\/jbc.M117.816868","article-title":"Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon","volume":"293","author":"Akuffo","year":"2018","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106004_bib48","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1084\/jem.187.11.1885","article-title":"Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset","volume":"187","author":"Haslett","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2025.106004_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: development, maturation, and clinical utilization","author":"Abel","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106004_bib50","doi-asserted-by":"crossref","first-page":"724","DOI":"10.18632\/aging.101774","article-title":"CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age","volume":"11","author":"M\u00fcller-Durovic","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106004_bib51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chom.2021.01.006","article-title":"HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses","volume":"29","author":"Clayton","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106004_bib52","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/1078-0432.CCR-21-3364","article-title":"Safety, activity, and long-term outcomes of pomalidomide in the treatment of kaposi sarcoma among individuals with or without HIV infection","volume":"28","author":"Ramaswami","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"15_suppl","key":"10.1016\/j.ebiom.2025.106004_bib53","doi-asserted-by":"crossref","first-page":"TPS11586","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS11586","article-title":"A phase I trial of pomalidomide in combination with liposomal doxorubicin in the treatment of advanced or refractory Kaposi sarcoma in individuals with or without HIV","volume":"36","author":"Ramaswami","year":"2018","journal-title":"JCO"},{"key":"10.1016\/j.ebiom.2025.106004_bib54","doi-asserted-by":"crossref","first-page":"xi35","DOI":"10.1093\/annonc\/mdz451.005","article-title":"Clearance of HPV anal premalignant lesions and modulation of systemic immune responses to HPV oncogenes with low dose pomalidomide","volume":"30","author":"Polizzotto","year":"2019","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106004_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002097","article-title":"Use of pembrolizumab with or without pomalidomide in HIV-associated non-hodgkin\u2019s lymphoma","volume":"9","author":"Lurain","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106004_bib56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood.V98.1.210","article-title":"Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma","volume":"98","author":"Davies","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106004_bib57","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1089\/jir.2005.25.604","article-title":"Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT","volume":"25","author":"Payvandi","year":"2005","journal-title":"J Interferon Cytokine Res"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106004_bib58","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1124\/jpet.102.048496","article-title":"Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs","volume":"305","author":"Schafer","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106004_bib59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/molecules25020367","article-title":"Immunomodulatory drugs alter the metabolism and the extracellular release of soluble mediators by normal monocytes","volume":"25","author":"Rundgren","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106004_bib60","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood-2005-12-4827","article-title":"Differential regulation of T-cell growth by IL-2 and IL-15","volume":"108","author":"Cornish","year":"2006","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.ebiom.2025.106004_bib61","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1182\/blood.V122.21.3475.3475","article-title":"Low-Dose IL-2 induces Bcl2 expression and resistance to apoptosis in CD4 regulatory T cells","volume":"122","author":"Murase","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106004_bib62","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.052676899","article-title":"Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death","volume":"99","author":"Cheng","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106004_bib63","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/2159-8290.CD-23-1266","article-title":"IL2 targeted to CD8+ T cells promotes robust effector T-cell responses and potent antitumor immunity","volume":"14","author":"Moynihan","year":"2024","journal-title":"Cancer Discov"},{"issue":"7109","key":"10.1016\/j.ebiom.2025.106004_bib64","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"issue":"7077","key":"10.1016\/j.ebiom.2025.106004_bib65","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.ebiom.2025.106004_bib66","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.2020006372","article-title":"Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates","volume":"136","author":"Rust","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106004_bib67","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/infdis\/jix191","article-title":"Clinical trial of the Anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy","volume":"215","author":"Gay","year":"2017","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106004_bib68","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/QAD.0000000000002919","article-title":"The impact of immune checkpoint therapy on the latent reservoir in HIV infected individuals with cancer on antiretroviral therapy","volume":"35","author":"Lau","year":"2021","journal-title":"AIDS"},{"issue":"7926","key":"10.1016\/j.ebiom.2025.106004_bib69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41586-022-05105-1","article-title":"MYB orchestrates T cell exhaustion and response to checkpoint inhibition","volume":"609","author":"Tsui","year":"2022","journal-title":"Nature"},{"issue":"311","key":"10.1016\/j.ebiom.2025.106004_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac8155","article-title":"IL-2R\u03b1 mediates temporal regulation of IL-2 signaling and enhances immunotherapy","volume":"7","author":"Su","year":"2015","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106004_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153604","article-title":"Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicity","volume":"132","author":"Ren","year":"2022","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106004_bib72","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4049\/jimmunol.2000228","article-title":"Batf 3 expression by CD8 T cells critically regulates the development of memory populations","volume":"205","author":"Qiu","year":"2020","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106004_bib73","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/s41588-023-01554-0","article-title":"Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens","volume":"55","author":"McCutcheon","year":"2023","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106004_bib74","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","article-title":"Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-\u03b1","volume":"163","author":"Corral","year":"1999","journal-title":"J Immunol"},{"issue":"29","key":"10.1016\/j.ebiom.2025.106004_bib75","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1073\/pnas.1302090110","article-title":"Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation","volume":"110","author":"Marras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106004_bib76","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cell.2017.11.037","article-title":"Natural killer cells control tumor growth by sensing a growth factor","volume":"172","author":"Barrow","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106004_bib77","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.2004.05286.x","article-title":"Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application","volume":"128","author":"Hayashi","year":"2005","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.ebiom.2025.106004_bib78","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1182\/blood.V124.21.2124.2124","article-title":"SAR650984 (SAR) directly promotes homotypic adhesion-related multiple myeloma (MM) cell death and SAR-induced Anti-MM activities are enhanced by pomalidomide, more potently than lenalidomide","volume":"124","author":"Jiang","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106004_bib79","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007096","article-title":"HIV latency","volume":"1","author":"Siliciano","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106004_bib80","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1172\/JCI132374","article-title":"BCL-2 antagonism sensitizes cytotoxic T cell\u2013resistant HIV reservoirs to elimination ex vivo","volume":"130","author":"Ren","year":"2020","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106004_bib81","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.immuni.2018.04.004","article-title":"Anti-apoptotic protein BIRC5 maintains survival of HIV-1-Infected CD4+ T cells","volume":"48","author":"Kuo","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2025.106004_bib82","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-022-05538-8","article-title":"Phenotypic signatures of immune selection in HIV-1 reservoir cells","volume":"614","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106004_bib83","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136648","article-title":"TCF-1 regulates HIV-specific CD8+ T cell expansion capacity","volume":"6","author":"Rutishauser","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106004_bib84","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/JVI.01754-06","article-title":"Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection","volume":"81","author":"Day","year":"2007","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.ebiom.2025.106004_bib85","doi-asserted-by":"crossref","first-page":"10735","DOI":"10.1128\/JVI.01527-15","article-title":"The breadth of expandable memory CD8+ T cells inversely correlates with residual viral loads in HIV elite controllers","volume":"89","author":"Ndhlovu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2025.106004_bib86","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41467-023-44389-3","article-title":"Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells","volume":"15","author":"Passaes","year":"2024","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.ebiom.2025.106004_bib87","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1097\/QAD.0000000000003722","article-title":"Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection","volume":"37","author":"van Paassen","year":"2023","journal-title":"AIDS"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425004487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425004487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:55:00Z","timestamp":1766166900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425004487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":87,"alternative-id":["S2352396425004487"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106004","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pomalidomide enhances CD8+ T and NK cell mediated killing of HIV-infected cells","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106004"}}